Trial · NCT00763971
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale-fourth Edition (ADHD-RS-IV) Total Score at up to 7 Weeks | Lisdexamfetamine Dimesylate (LDX) | -24.3 | Standard Error 1.16 | Scores on a scale | |
| Change From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale-fourth Edition (ADHD-RS-IV) Total Score at up to 7 Weeks | Methylphenidate Hydrochloride | -18.7 | Standard Error 1.14 | Scores on a scale | |
| Change From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale-fourth Edition (ADHD-RS-IV) Total Score at up to 7 Weeks | Placebo | -5.7 | Standard Error 1.13 | Scores on a scale | |
| Percentage of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) Scores | Lisdexamfetamine Dimesylate (LDX) | 78.0 | percentage of participants | ||
| Percentage of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) Scores | Methylphenidate Hydrochloride | 60.6 | percentage of participants | ||
| Percentage of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) Scores | Placebo | 14.4 | percentage of participants | ||
| Change From Baseline in Conner's Parent Rating Scale - Revised (CPRS-R) Total Score at up to 7 Weeks | Lisdexamfetamine Dimesylate (LDX) | -24.5 | Standard Error 1.70 | Scores on a scale | |
| Change From Baseline in Conner's Parent Rating Scale - Revised (CPRS-R) Total Score at up to 7 Weeks | Methylphenidate Hydrochloride | -18.4 | Standard Error 1.69 | Scores on a scale | |
| Change From Baseline in Conner's Parent Rating Scale - Revised (CPRS-R) Total Score at up to 7 Weeks | Placebo | -3.2 | Standard Error 1.69 | Scores on a scale | |
| Health Utilities Index-2 (HUI-2) Scores at up to 7 Weeks | Lisdexamfetamine Dimesylate (LDX) | Baseline | 0.811 | Standard Deviation 0.1451 | Scores on a scale |
| Health Utilities Index-2 (HUI-2) Scores at up to 7 Weeks | Methylphenidate Hydrochloride | Baseline | 0.822 | Standard Deviation 0.1377 | Scores on a scale |
| Health Utilities Index-2 (HUI-2) Scores at up to 7 Weeks | Placebo | Baseline | 0.806 | Standard Deviation 0.1460 | Scores on a scale |
| Health Utilities Index-2 (HUI-2) Scores at up to 7 Weeks | Lisdexamfetamine Dimesylate (LDX) | Up to 7 weeks | 0.878 | Standard Deviation 0.1322 | Scores on a scale |
| Health Utilities Index-2 (HUI-2) Scores at up to 7 Weeks | Methylphenidate Hydrochloride | Up to 7 weeks | 0.887 | Standard Deviation 0.1151 | Scores on a scale |
| Health Utilities Index-2 (HUI-2) Scores at up to 7 Weeks | Placebo | Up to 7 weeks | 0.843 | Standard Deviation 0.1431 | Scores on a scale |
| Change From Baseline in the Child Health and Illness Profile, Child Edition: Parent Report Form (CHIP-CE:PRF) Global T-score at up to 7 Weeks | Lisdexamfetamine Dimesylate (LDX) | 8.6 | Standard Error 1.08 | T-scores | |
| Change From Baseline in the Child Health and Illness Profile, Child Edition: Parent Report Form (CHIP-CE:PRF) Global T-score at up to 7 Weeks | Methylphenidate Hydrochloride | 7.1 | Standard Error 1.10 | T-scores | |
| Change From Baseline in the Child Health and Illness Profile, Child Edition: Parent Report Form (CHIP-CE:PRF) Global T-score at up to 7 Weeks | Placebo | -0.2 | Standard Error 1.07 | T-scores | |
| Change From Baseline in Weiss Functional Impairment Rating Scale - Parent Report (WFIRS-P) Global Score at up to 7 Weeks | Lisdexamfetamine Dimesylate (LDX) | -0.3 | Standard Error 0.04 | Scores on a scale | |
| Change From Baseline in Weiss Functional Impairment Rating Scale - Parent Report (WFIRS-P) Global Score at up to 7 Weeks | Methylphenidate Hydrochloride | -0.3 | Standard Error 0.04 | Scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00763971/results